Simon Peter P - OmicsDI

Show results for

Genomics (128)
Unknown (127)
Transcriptomics (39)
Proteomics (10)
Metabolomics (3)
Models (1)
Genomic (1)

Organisms

Homo sapiens (143)
Mus musculus (16)
Moraxella catarrhalis BBH18 (2)
Arabidopsis thaliana (2)
Capsella grandiflora (1)
Rubus idaeus (1)
Staphylococcus aureus (1)
Caenorhabditis elegans (1)
Triticum aestivum (1)
Drosophila melanogaster (1)

Repository

EGA (124)
biostudies-arrayexpress (43)
MassIVE (6)
MetaboLights (3)
PeptideAtlas (2)
BioModels (1)
dbGaP (1)
PanoramaPublic (1)
pride (1)
ENA (1)

Disease

Cancer (1)

Technology Type

Illumina 15K (8)
Mass spectrometry (2)
ABI_SOLID, Illumina Genome Analyzer IIx, Affymetrix_GenomeWide_SNP6.34 (1)
Affymetrix 6.0 (1)
Affymetrix 6.0, Illumina_670k - Illuminus, Illumina 1.2M (1)
CAPILLARY, AB 3730xL Genetic Analyzer (1)
ILLUMINA, Illumina HiSeq 2500, HiSeq X Ten, Illumina HiSeq 2000 (1)
Illumina 1.2M, Affymetrix 6.0 (1)
Illumina 1.2M, Affymetrix 6.0, Affymetrix 6.0 - CHIAMO (1)
Illumina 1.2M, Illumina 610K Quad, Affymetrix 6.0 (1)
Illumina Genome Analyzer II, Affymetrix snp 6.0, Illumina Genome Analyzer IIx, GPL570, Affymetrix GeneChip Human Genome U133 plus 2.0 (1)
Illumina HiSeq 2000 (1)
Illumina HiSeq 2000, HumanMethylation450k Bead Chip - Genome Studio, Illumina Genome Analyzer IIx (1)
Illumina HiSeq 2500 (1)
Illumina HiSeq 2500, Illumina HiSeq 2000 (1)
Illumina HumanExome-12v1_A-GenCall, zCall, GenoSNP, - Illuminus (1)
Illumina HumanHap 550K, Illumina HumanHap300-Duo (1)
Illumina OncoArray (1)
Illumina_670k - Illuminus, Affymetrix 6.0, Illumina 1.2M (1)
Mass spectrometry assay (1)
NMR spectroscopy (1)
Gel-based experiment (1)
Mass Spectrometry (1)

Instrument Platform

Q Exactive (4)
Q TRAP (4)
Illumina HiSeq 2500 (2)
Q Exactive HF (2)
LTQ Orbitrap Velos (2)
HiSeq 2000 (1)
ArrayWoRx Biochip Reader [Applied Precision] (1)
GenePix Personal 4100A [Axon Instruments] (1)
Illumina HiSeq 1000 (1)
Illumina NovaSeq 6000 (1)
Illumina HiSeq 2000 (1)
Illumina HiSeq 4000 (1)
TripleTOF 6600 (1)
Gas Chromatography MS - positive - medium polarity - Agilent 6890 GC - LECO Pegasus III TOF MS (LECO) (1)
Liquid Chromatography MS - negative - hilic (1)
Liquid Chromatography MS - positive - hilic (1)
Liquid Chromatography MS - positive - reverse phase (1)
MS Imaging - (1)
Nuclear Magnetic Resonance (NMR) - (1)

Publication Date

2013 (10)
2014 (8)
2021 (6)
2011 (6)
2015 (5)
2012 (4)
2022 (2)
2016 (2)
2010 (2)
2007 (2)
2025 (2)
2024 (1)
2020 (1)
2019 (1)
2018 (1)
2009 (1)
2006 (1)
2023 (1)

UNIPROT ID/AC

A0A4W9 (2)
A0JNU2 (2)
A0JNY3 (2)
A0JNY7 (2)
A0JP53 (2)
A0PJL3 (2)
A0PJN6 (2)
A0ZV96 (2)
A1ILG8 (2)
A1L0U3 (2)
A1L0U6 (2)
A1L341 (2)
A1L347 (2)
A1L3B8 (2)
A1L3P4 (2)
A2A432 (2)
P01116 (1)
P04049 (1)
P04626 (1)
P21860 (1)
P27361 (1)
P29353 (1)
P31749 (1)
P60484 (1)
P62993 (1)
P63151 (1)
Q02297 (1)
Q02750 (1)
Q07889 (1)
Q07890 (1)

ENSEMBL ID

ENSMUSG00000098557 (2)
ENSMUSP00000141097 (2)
ENSMUSP00000141542 (2)

CHEBI ID

CHEBI:15356 (2)
CHEBI:16027 (2)
CHEBI:16680 (2)
CHEBI:16856 (2)
CHEBI:17126 (2)
CHEBI:17268 (2)
CHEBI:17822 (2)
CHEBI:17992 (2)
CHEBI:18012 (2)
CHEBI:18237 (2)
CHEBI:24898 (2)
CHEBI:27570 (2)
CHEBI:28044 (2)
CHEBI:28300 (2)
CHEBI:29016 (2)
CHEBI:30769 (2)
CHEBI:6650 (2)
CHEBI:15552 (1)
CHEBI:15996 (1)
CHEBI:16618 (1)
CHEBI:17552 (1)
CHEBI:12937 (1)
CHEBI:14314 (1)
CHEBI:14314|CHEBI:16077 (1)
CHEBI:15347 (1)
CHEBI:15366 (1)
CHEBI:15414 (1)
CHEBI:15428 (1)
CHEBI:15584 (1)
CHEBI:15603 (1)

Metabolite Name

1,2-butandiol (1)
1,2-ethylene glycol (1)
1,3-propanediol (1)
1,6-anhydroglucose (1)
1-monohexadecanoylglycerol (1)
2,4-dimethylbenzoic acid (1)
2-furaldehyde (1)
2-hydroxyglutaric acid (1)
2-hydroxyphenylethanol (1)
2-isopropyl-malic acid (1)
2-ketoglutaric acid (1)
3,4-dimethylenedioxy mandelic acid (1)
3-methyl 1,2-hydroxybutane (1)
3-phosphoglycerate (1)
4-deoxypyridoxine (1)
4-methyl, 2-hydroxy pentanoic acid (1)
5-HYDROXYINDOLEACETIC ACID (1)
5-hydroxy furancarboxylic acid (1)
6-DEOXY-L-GALACTOSE (1)
Acetyl-methionine (1)
Adenosylhomocysteine (1)
Cysteine (1)
Deoxyuridine (1)
GSSG (1)
Glutamate (1)
Glutamine (1)
Glutathione (reduced) (1)
Hypotaurine (1)
IsoLeucine (1)
L-CARNITINE (1)

IsPrivate

False (1)

First Public Date

2021 (1)

Modelling Approach

Ordinary differential equation model (1)

Study type

Transcription profiling by array (22)
RNA-seq of coding RNA (7)
Comparative genomic hybridization by array (2)
Other (2)
Methylation profiling by array (2)
Differential (1)
Transcription profiling by tiling array (1)
ChIP-chip by array (1)
ChIP-seq (1)
DNA-seq (1)
Methylation profiling by high throughput sequencing (1)
RNA-seq of non coding RNA (1)

Release Date

2015 (18)
2021 (16)
2013 (14)
2022 (13)
2020 (13)
2014 (12)
2025 (11)
2024 (10)
2023 (9)
2018 (8)
2016 (8)
2011 (8)
2019 (7)
2017 (7)
2010 (5)
2012 (4)
2007 (2)
2026 (2)
2009 (1)
2006 (1)
2005 (1)

Lab affiliation

Department of Biology, University of Konstanz, Germany (1)

Previous page
1 / 31
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 31
Next page

Sort by:

Relevance

Page size

Identification of genes essential for Moraxella catarrhalis growth under iron-limiting conditions using Genomic Array Footprinting (GAF)

Iron-sequestration by the human host is a first line defense against respiratory pathogens like Moraxella catarrhalis, which consequently experiences a period of iron-starvation during colonization and infection. We determined the genetic requirements for M. catarrhalis growth during iron-starvation...

ORGANISM(S): Moraxella catarrhalis BBH18

2013-06-06 | E-GEOD-41546 | biostudies-arrayexpress

Identification of genes essential for Moraxella catarrhalis growth under iron-limiting conditions using Genomic Array Footprinting (GAF): Expression analysis of directed gene deletion mutants.

ORGANISM(S): Moraxella catarrhalis BBH18

2013-06-06 | E-GEOD-41547 | biostudies-arrayexpress

Strong and lasting impacts of past global warming on baleen whales and their prey

PRJNA791939 | ENA

States With Substantial Increases In Buprenorphine Uptake Did So With Increased Medicaid Prescribing, 2018-24.

Not available

S-EPMC12665180 | biostudies-literature

Phase 1 Dose-Escalation Study of Pegylated Arginine Deiminase, Cisplatin, and Pemetrexed in Patients With Argininosuccinate Synthetase 1-Deficient Thoracic Cancers.

Not available